Levothyroxine Sodium
NDC 25021-469, Levothyroxine Sodium Anhydrous, injection, powder, lyophilized, for solution, from Sagent Pharmaceuticals.
- Product NDC
- 25021-469
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208749
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-469 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOTHYROXINE SODIUM ANHYDROUS200 ug/5mL
Pharmacologic classes
Thyroxine [CS]; l-Thyroxine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-469-10 | 25021046910 | 1 VIAL in 1 CARTON (25021-469-10) / 5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f57e9b19-6f17-4520-80fc-511322cc56c9Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-469
Use it
Look up 25021-469 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-469 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-469. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.